Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.

NCT07483645 — Active not recruiting, 74 participants, Carnot Laboratories

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effectiveness and Acceptability of a Liposomal Iron Supplement With Vitamin C and Fiber (LISEFEX®): Observational, Descriptive, Prospective, Longitudinal, Multicenter Study in Mexican Subjects Diagnosed With Mild to Moderate Iron Deficiency Anemia.

RegistryNCT07483645
StatusActive not recruiting
Study typeObservational
Enrollment74 (Actual)
SponsorCarnot Laboratories (Industry)
ConditionsIron Deficiency Anemia
Datesstart 2025-05-06, primary completion 2026-02-15, completion 2026-03-30 (estimated), first posted 2026-03-19, last updated 2026-03-19
Locations1 site in Mexico

Related Papers Related Patents Related Grants Related Experts
All trials for Iron Deficiency Anemia

-Summary

Observational, descriptive, prospective, longitudinal, multicenter, non-interventionist and multicentric study in Mexican subjects diagnosed with mild to moderate iron deficiency anemia (ADH). Main objective:To evaluate the effectiveness and acceptability of LISEFEX® supplement in patients with mild to moderate iron deficiency anemia.Design The minimal risk study, no therapeutic interventions were carried out by the research team. The indication for supplementation with LISEFEX® was made by the treating physician as part of standard clinical practice, while the study was limited to systematic collection of clinical and laboratory information during participant follow-up.

Expand all sections  ·  Collapse all

+Detailed description

The primary objective of this study was to describe the evolution of hemoglobin levels from baseline to weeks 1, 2, 4, 8 and 12 of supplementation with LISEFEX®.

Secondary objectives, the aim is to describe various hematological, biochemical and safety parameters throughout the follow-up period in both cohorts. In particular, the percentage of reticulocytes was evaluated basal and in weeks 2, 4, 8 and 12 of supplementation. Also, the values of mean corpuscular volume (MCV), mean corpuscular hemoglobin (HCM) and corpuscular hemoglobin concentration were described mean (CHCM) baseline and follow-up weeks 1, 2, 4, 8, and 12.

+Arms and interventions

ArmTypeInterventionsDescription
Grupo 1two sachets of LISEFEX® daily
Gurpo 2two packets of LISEFEX® on alternate days.

+Outcome measures

Primary outcomes

  • Hemoglobin level [12 weeks]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Clinical diagnosis of iron deficiency anemia.
* Candidates over 18 years.
* Candidates with Informed Consent signed.
* Candidates who have been instructed by their treating physician to start treatment with LISEFEX
* Candidates with the ability to swallow substances orally.

Exclusion Criteria:

* Pregnancy or breastfeeding.
* Having received any treatment in the last 3 months for iron deficiency anemia.

+Locations (1)

FacilityCityCountryStatus
Winsett Rethman S.A. de C.V.Monterrey, Nuevo LeónMexico

+Publications

  • Results publication: Guideline on haemoglobin cutoffs to define anaemia in individuals and populations [Internet]. Geneva: World Health Organization; 2024. Available from http://www.ncbi.nlm.nih.gov/books/NBK602198/ PMID 38530913
  • Results publication: Waldvogel-Abramowski S, Waeber G, Gassner C, Buser A, Frey BM, Favrat B, Tissot JD. Physiology of iron metabolism. Transfus Med Hemother. 2014 Jun;41(3):213-21. doi: 10.1159/000362888. Epub 2014 May 12. PMID 25053935
  • Results publication: von Siebenthal HK, Gessler S, Vallelian F, Steinwendner J, Kuenzi UM, Moretti D, Zimmermann MB, Stoffel NU. Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. EClinicalMedicine. 2023 Nov 3;65:102286. doi: 10.1016/j.eclinm.2023.102286. eCollection 2023 Nov. PMID 38021373
  • Results publication: Ucan A, Kaya ZI, Yilmaz EO, Vasi I, Ozgeyik MO. Comparing therapeutic effects of alternate day versus daily oral iron in women with iron deficiency anemia: A retrospective cohort study. Medicine (Baltimore). 2023 Jul 28;102(30):e34421. doi: 10.1097/MD.0000000000034421. PMID 37505179
  • Results publication: Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020 May;105(5):1232-1239. doi: 10.3324/haematol.2019.220830. Epub 2019 Aug 14. PMID 31413088
  • Results publication: Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant. 2015 Apr;30(4):645-52. doi: 10.1093/ndt/gfu357. Epub 2014 Nov 13. PMID 25395392
  • Results publication: Obeagu EI, Obeagu GU, Ukibe NR, Oyebadejo SA. Anemia, iron, and HIV: decoding the interconnected pathways: A review. Medicine (Baltimore). 2024 Jan 12;103(2):e36937. doi: 10.1097/MD.0000000000036937. PMID 38215133
  • Results publication: Mejia-Rodriguez F, Mundo-Rosas V, Garcia-Guerra A, Mauricio-Lopez ER, Shamah-Levy T, Villalpando S, De la Cruz-Gongora V. Prevalencia de anemia en la poblacion mexicana: analisis de la Ensanut Continua 2022. Salud Publica Mex. 2023 Jun 14;65:s225-s230. doi: 10.21149/14771. Spanish. PMID 38060969
  • Results publication: Mastrogiannaki M, Matak P, Peyssonnaux C. The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. Blood. 2013 Aug 8;122(6):885-92. doi: 10.1182/blood-2012-11-427765. Epub 2013 May 15. PMID 23678007
  • Results publication: Malhotra J, Garg R, Malhotra N, Agrawal P. Oral Liposomal Iron: A Treatment Proposal for Anemia. World J Anemia 2017;1(4):1-6.
  • Results publication: Li N, Zhao G, Wu W, Zhang M, Liu W, Chen Q, Wang X. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial. JAMA Netw Open. 2020 Nov 2;3(11):e2023644. doi: 10.1001/jamanetworkopen.2020.23644. PMID 33136134
  • Results publication: Kaundal R, Bhatia P, Jain A, Jain A, Nampoothiri RV, Mishra K, Jandial A, Goni D, Sandal R, Jindal N, Meshram A, Sharma R, Khaire N, Singh C, Khadwal A, Prakash G, Das R, Varma N, Varma S, Malhotra P, Lad DP. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID 31811360
  • Results publication: Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a Novel Food Supplement (Ferfer(R)) Containing Microencapsulated Iron in Liposomal Form in Female Iron Deficiency Anemia. Cureus. 2019 May 7;11(5):e4603. doi: 10.7759/cureus.4603. PMID 31309026
  • Results publication: Hess SY, McLain AC, Frongillo EA, Afshin A, Kassebaum NJ, Osendarp SJM, Atkin R, Rawat R, Brown KH. Challenges for Estimating the Global Prevalence of Micronutrient Deficiencies and Related Disease Burden: A Case Study of the Global Burden of Disease Study. Curr Dev Nutr. 2021 Nov 18;5(12):nzab141. doi: 10.1093/cdn/nzab141. eCollection 2021 Dec. PMID 34993390
  • Results publication: Gomez-Ramirez S, Brilli E, Tarantino G, Munoz M. Sucrosomial(R) Iron: A New Generation Iron for Improving Oral Supplementation. Pharmaceuticals (Basel). 2018 Oct 4;11(4):97. doi: 10.3390/ph11040097. PMID 30287781
  • Results publication: Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut. 2011 Oct;60(10):1309-16. doi: 10.1136/gut.2010.228874. Epub 2011 May 11. PMID 21561874
  • Results publication: GBD 2021 Anaemia Collaborators. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematol. 2023 Sep;10(9):e713-e734. doi: 10.1016/S2352-3026(23)00160-6. Epub 2023 Jul 31. PMID 37536353
  • Results publication: Eichner ER. Anemia in Athletes, News on Iron Therapy, and Community Care During Marathons. Curr Sports Med Rep. 2018 Jan;17(1):2-3. doi: 10.1249/JSR.0000000000000435. No abstract available. PMID 29315098
  • Results publication: Ding B, Yi X, Li L, Yang H. Assessment of ferrous glycinate liposome absorption using in situ single-pass perfusion model. Int J Food Eng 2017 Aug;13(9):0358.
  • Results publication: Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr. 2001 Jan;73(1):93-8. doi: 10.1093/ajcn/73.1.93. PMID 11124756
  • Results publication: Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019 Aug;1450(1):15-31. doi: 10.1111/nyas.14092. Epub 2019 Apr 22. PMID 31008520
  • Results publication: Cengiz A, Kahyaoglu T, Schroen K, Berton-Carabin C. Oxidative stability of emulsions fortified with iron: the role of liposomal phospholipids. J Sci Food Agric. 2019 Apr;99(6):2957-2965. doi: 10.1002/jsfa.9509. Epub 2019 Jan 17. PMID 30471119
  • Results publication: Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020 Feb;287(2):153-170. doi: 10.1111/joim.13004. Epub 2019 Nov 12. PMID 31665543
  • Results publication: Brugnara C. A hematologic "gold standard" for iron-deficient states? Clin Chem. 2002 Jul;48(7):981-2. No abstract available. PMID 12089163
  • Results publication: Bastida G, Herrera-de Guise C, Algaba A, Ber Nieto Y, Soares JM, Robles V, Bermejo F, Saez-Gonzalez E, Gomollon F, Nos P. Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment. Nutrients. 2021 May 22;13(6):1770. doi: 10.3390/nu13061770. PMID 34067320
  • Results publication: Baomiao D, Xiangzhou Y, Li L, Hualin Y. Evaluation of iron transport from ferrous glycinate liposomes using Caco-2 cell model. Afr Health Sci. 2017 Sep;17(3):933-941. doi: 10.4314/ahs.v17i3.37. PMID 29085422
  • Results publication: Banerjee A, Athalye S, Shingade P, Khargekar V, Mahajan N, Madkaikar M, Khargekar N. Efficacy of daily versus intermittent oral iron supplementation for prevention of anaemia among pregnant women: a systematic review and meta-analysis. EClinicalMedicine. 2024 Jul 17;74:102742. doi: 10.1016/j.eclinm.2024.102742. eCollection 2024 Aug. PMID 39114275

+Investigators